| Followers | 842 |
| Posts | 122787 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Wednesday, June 14, 2023 4:53:54 PM
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001570562/000157056223000079/eols-20230609.htm
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent EOLS News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:43:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/03/2026 10:08:29 PM
- Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 • Business Wire • 03/03/2026 09:05:00 PM
- Evolus to Participate in The Leerink Partners Global Healthcare Conference • Business Wire • 02/25/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:57:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:57:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:57:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:57:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:57:23 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:56:52 PM
- Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 • Business Wire • 02/17/2026 01:00:00 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/13/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 01:34:50 PM
- Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue • Business Wire • 01/09/2026 01:30:00 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 11/14/2025 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 10:02:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 09:12:37 PM
- Evolus Reports Third Quarter 2025 Financial Results • Business Wire • 11/05/2025 09:05:00 PM
- Evolus to Participate in 2025 Stifel Healthcare Conference • Business Wire • 10/28/2025 12:00:00 PM
- Evolus to Report Third Quarter Financial Results on November 5, 2025 • Business Wire • 10/22/2025 12:00:00 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/10/2025 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 08:57:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 08:57:18 PM
- Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch • PR Newswire (US) • 09/22/2025 01:03:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
